Comparative Efficacy and Safety of Advanced Intravitreal Therapeutic Agents for Noninfectious Uveitis: A Systematic Review and Network Meta-Analysis
Background: To compare the efficacy and safety of advanced intravitreal therapeutic regimens, including a dexamethasone implant at 350 and 700 μg; a fluocinolone acetonide (FA) implant, 0.2 µg/day, 0.59 and 2.1 mg; intravitreal bevacizumab, 1.25 mg; intravitreal ranibizumab, 0.5 mg; intravitreal tri...
Main Authors: | Weiting Liao, Zhenyu Zhong, Guannan Su, Xiaojie Feng, Peizeng Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.749312/full |
Similar Items
-
Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis
by: Eugene Yu-Chuan Kang, et al.
Published: (2021-08-01) -
Adalimumab combined with Dexamethasone intravitreal implant in the treatment of refractory noninfectious uveitis macular edema
by: Sui Yuan, et al.
Published: (2024-01-01) -
Role of Calixarene in Chemotherapy Delivery Strategies
by: Rossella Basilotta, et al.
Published: (2021-06-01) -
The Treatment of Diabetic Retinal Edema with Intravitreal Steroids: How and When
by: Maria Letizia Salvetat, et al.
Published: (2024-02-01) -
Case Report: Successful treatment of external beam radiation-induced optic papillopathy with intravitreal anti-VEGF
by: Andrew R. Carey
Published: (2023-04-01)